These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 18442485)

  • 1. Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones.
    Wang HH; Portincasa P; Mendez-Sanchez N; Uribe M; Wang DQ
    Gastroenterology; 2008 Jun; 134(7):2101-10. PubMed ID: 18442485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ezetimibe prevents the formation of oestrogen-induced cholesterol gallstones in mice.
    de Bari O; Wang HH; Portincasa P; Paik CN; Liu M; Wang DQ
    Eur J Clin Invest; 2014 Dec; 44(12):1159-68. PubMed ID: 25303682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezetimibe prevents cholesterol gallstone formation in mice.
    Zúñiga S; Molina H; Azocar L; Amigo L; Nervi F; Pimentel F; Jarufe N; Arrese M; Lammert F; Miquel JF
    Liver Int; 2008 Aug; 28(7):935-47. PubMed ID: 18783541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol.
    Wang HH; Portincasa P; de Bari O; Liu KJ; Garruti G; Neuschwander-Tetri BA; Wang DQ
    Eur J Clin Invest; 2013 Apr; 43(4):413-26. PubMed ID: 23419155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LXR driven induction of HDL-cholesterol is independent of intestinal cholesterol absorption and ABCA1 protein expression.
    Kannisto K; Gåfvels M; Jiang ZY; Slätis K; Hu X; Jorns C; Steffensen KR; Eggertsen G
    Lipids; 2014 Jan; 49(1):71-83. PubMed ID: 24163219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.
    Wang HH; Portincasa P; Wang DQ
    Eur J Clin Invest; 2016 Feb; 46(2):158-69. PubMed ID: 26683129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization.
    Uppal H; Zhai Y; Gangopadhyay A; Khadem S; Ren S; Moser JA; Xie W
    Hepatology; 2008 Apr; 47(4):1331-42. PubMed ID: 18318438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Inhibition of Intestinal Cholesterol Absorption on the Prevention of Cholesterol Gallstone Formation.
    Portincasa P; Wang DQ
    Med Chem; 2017; 13(5):421-429. PubMed ID: 28185534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dramatically increased intestinal absorption of cholesterol following hypophysectomy is normalized by thyroid hormone.
    Gälman C; Bonde Y; Matasconi M; Angelin B; Rudling M
    Gastroenterology; 2008 Apr; 134(4):1127-36. PubMed ID: 18395092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that the adenosine triphosphate-binding cassette G5/G8-independent pathway plays a determinant role in cholesterol gallstone formation in mice.
    Wang HH; Li X; Patel SB; Wang DQ
    Hepatology; 2016 Sep; 64(3):853-64. PubMed ID: 27014967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothyroidism Increases Cholesterol Gallstone Prevalence in Mice by Elevated Hydrophobicity of Primary Bile Acids.
    Kube I; Tardio LB; Hofmann U; Ghallab A; Hengstler JG; Führer D; Zwanziger D
    Thyroid; 2021 Jun; 31(6):973-984. PubMed ID: 33231505
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of cholesterol absorption by SCH 58053 in the mouse is not mediated via changes in the expression of mRNA for ABCA1, ABCG5, or ABCG8 in the enterocyte.
    Repa JJ; Dietschy JM; Turley SD
    J Lipid Res; 2002 Nov; 43(11):1864-74. PubMed ID: 12401885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiota prevents cholesterol loss from the body by regulating host gene expression in mice.
    Zhong CY; Sun WW; Ma Y; Zhu H; Yang P; Wei H; Zeng BH; Zhang Q; Liu Y; Li WX; Chen Y; Yu L; Song ZY
    Sci Rep; 2015 May; 5():10512. PubMed ID: 26015368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia.
    Salen G; von Bergmann K; Lütjohann D; Kwiterovich P; Kane J; Patel SB; Musliner T; Stein P; Musser B;
    Circulation; 2004 Mar; 109(8):966-71. PubMed ID: 14769702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of beta-muricholic acid on the prevention and dissolution of cholesterol gallstones in C57L/J mice.
    Wang DQ; Tazuma S
    J Lipid Res; 2002 Nov; 43(11):1960-8. PubMed ID: 12401895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveolin-1 is not required for murine intestinal cholesterol transport.
    Valasek MA; Weng J; Shaul PW; Anderson RG; Repa JJ
    J Biol Chem; 2005 Jul; 280(30):28103-9. PubMed ID: 15919660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced susceptibility to cholesterol gallstone formation in mice that do not produce apolipoprotein B48 in the intestine.
    Wang HH; Wang DQ
    Hepatology; 2005 Oct; 42(4):894-904. PubMed ID: 16175613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters.
    Valasek MA; Repa JJ; Quan G; Dietschy JM; Turley SD
    Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G813-22. PubMed ID: 18718997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic Mttp deletion reverses gallstone susceptibility in L-Fabp knockout mice.
    Xie Y; Fung HY; Newberry EP; Kennedy S; Luo J; Crooke RM; Graham MJ; Davidson NO
    J Lipid Res; 2014 Mar; 55(3):540-8. PubMed ID: 24474819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmented cholesterol absorption and sarcolemmal sterol enrichment slow small intestinal transit in mice, contributing to cholesterol cholelithogenesis.
    Xie M; Kotecha VR; Andrade JD; Fox JG; Carey MC
    J Physiol; 2012 Apr; 590(8):1811-24. PubMed ID: 22331417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.